Sort
51,593 grants matching “hepatitis”
Clinical Trials Units for NIAID Networks (UM1)
$3,411,797Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2020 · AI
Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST)
$3,411,692Susanna Naggie · Duke University · U01 · FY2025 · AI
Gut Liver Brain Biochemical Axis in Alzheimer's Disease
$3,407,970Rima F Kaddurah-Daouk · Duke University · RF1 · FY2018 · AG
Study of Viral Resistance to Antiviral Therapy of Chron*
$3,400,000University Of Pittsburgh At Pittsburgh · U01 · FY2002 · DK
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
$3,400,000Matthias Egger · Universitat Bern · U01 · FY2021 · AI
MULTICENTER AIDS COHORT STUDY
$3,393,874Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AI
TCD With Transfusions Changing to Hydroxyurea
$3,387,494Russell E Ware · St. Jude Children'S Research Hospital · R01 · FY2009 · HL
Howard University Research Center for Minority Health and Health Disparities
$3,383,697William M Southerland · Howard University · U54 · FY2021 · MD
Howard University Research Center for Minority Health and Health Disparities
$3,383,697William M Southerland · Howard University · U54 · FY2020 · MD
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
$3,380,907Matthias Egger · Universitat Bern · U01 · FY2023 · AI
Epidemiology and Natural History of Cancer-Associated Viruses
$3,379,228Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$3,372,423Stephen A Spector · University Of California, San Diego · UM1 · FY2019 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit
$3,366,355John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2019 · AI
General Chemistry Support
$3,365,990Reshan Fernando · Research Triangle Institute · N01 · FY2020 · ES
The Connie Wofsy Women's HIV Study
$3,364,936University Of California San Francisco · U01 · FY2004 · AI
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,363,729Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Emerging Infections Programs
$3,362,308Richard Norman Danila · Minnesota State Dept Of Health · U01 · FY2010 · CI
Reagent Program for HIV and other Infectious Diseases
$3,362,223Sujatha Rashid · American Type Culture Collection · N01 · FY2023 · AI
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)
$3,352,002Charles W. Flexner · Johns Hopkins University · UM1 · FY2019 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$3,350,640Barry Coller · Rockefeller University · UL1 · FY2007 · RR
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER
$3,350,640Barry Coller · Rockefeller University · UL1 · FY2007 · RR
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$3,349,999Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2023 · HL
Mechanisms and biological consequences of the nuclear receptor CAR activation
$3,347,197Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
$3,331,239Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2024 · DA
Cancer Risk in Human Populations
$3,329,450Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA